Business Wire

State Street Strengthens Leadership Team with Appointment of Ann Fogarty

Share

State Street Corporation (NYSE:STT) today announced the appointment of Ann Fogarty to executive vice president and deputy head of Global Delivery with responsibility for State Street’s custody, middle office, transfer agency and client service operations. Fogarty will report to Liz Nolan, executive vice president and head of Global Delivery. She will also join State Street’s Management Committee.

Fogarty joins from BNY Mellon where she was most recently Executive Committee member responsible for leading the Global Operations organization and supporting every stage of the client investment lifecycle and overseeing a team of more than 20,000. She held a variety of senior positions since joining BNY Mellon in 1988, including head of EMEA Investment operations and managing director leading the provision of fund accounting, transfer agency and middle office services to mutual, ETF and alternative fund clients.

“Ann brings significant global operations expertise across all ranges of complex fund structures and jurisdictions,” said Nolan. “She has a keen understanding of the needs of our clients and her depth and breadth of capabilities, particularly in the custody and fund administration space, will help us continue to scale our operating model while providing our clients with continued high quality service and delivery.”

Fogarty has extensive experience in leading global, cross-business initiatives across all aspects of the trading lifecycle. She also has broad experience with the global regulatory environment having managed teams and projects across EMEA, Latin America and the APAC region.

“I look forward to this next chapter of my career and working with the global teams and clients to continue to build on the strong foundation of innovation and service excellence that State Street has established,” said Fogarty.

About State Street

State Street Corporation (NYSE: STT) is one of the world's leading providers of financial services to institutional investors including investment servicing, investment management and investment research and trading. With $38.8 trillion in assets under custody and/or administration and $3.5 trillion* in assets under management as of December 31, 2020, State Street operates globally in more than 100 geographic markets and employs approximately 39,000 worldwide. For more information, visit State Street's website at www.statestreet.com.

*Assets under management as of December 31, 2020 includes approximately $75 billion of assets with respect to SPDR® products for which State Street Global Advisors Funds Distributors, LLC (SSGA FD) acts solely as the marketing agent. SSGA FD and State Street Global Advisors are affiliated.

© 2021 State Street Corporation - All Rights Reserved

3482412.1.1.GBL.RTL

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Ed Patterson
EPatterson@StateStreet.com
+1 404 213 3106

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Accellix Appoints Dr. Félix A. Montero-Julian as Vice President of Scientific Affairs7.7.2025 15:00:00 EEST | Press release

Accellix, a global leader in rapid point of need cytometry solutions, is pleased to announce the appointment of Félix A. Montero-Julian, PhD as Vice President of Scientific Affairs. Dr. Montero-Julian brings more than 30 years of international experience in scientific affairs, analytical development, and regulatory science to support Accellix’s strategic vision and innovation roadmap. Dr. Montero-Julian joins Accellix from bioMérieux, where he most recently served as Scientific Senior Director of Pharma Quality Control. His previous roles include Cytometry R&D Director at bioMérieux and Director of the Cellular Analysis Department at Beckman Coulter, underscoring a distinguished track record spanning biopharmaceuticals, industrial microbiology, and clinical diagnostics. “I’m excited to join Accellix during this period of dynamic growth and innovation,” said Dr. Montero-Julian. “I have great confidence in the potential of the Accellix Platform to transform quality control in cell and ge

NTT DATA Appoints Anne-Sophie Lotgering as Europe CEO7.7.2025 14:00:00 EEST | Press release

NTT DATA, a global leader in digital business and technology services, today announced the appointment of Anne-Sophie Lotgering as the new Chief Executive Officer for Europe at NTT DATA, Inc., effective 1 September 2025. Lotgering succeeds Chieri Kimura and will report directly to NTT DATA, Inc. President and Global CEO, Abhijit Dubey. She will also join NTT DATA, Inc.’s Executive Leadership Team. Lotgering brings over two decades of leadership experience in IT services and telecommunications, with a strong track record in B2B2C and B2B sales, digital marketing and transformation. She joins NTT DATA from Proximus NXT IT where she served as CEO, overseeing the IT integration of B2B operations across the Netherlands, Luxembourg, and Belgium. Her recent achievements include the successful unification of multiple subsidiaries into a single, agile organization, strategically aligned with high-growth sectors such as cloud, cybersecurity and data. Her career spans senior roles at The Orange G

CorFlow Therapeutics Announces FDA Approval of the MOCA-II IDE Pivotal Trial to Validate a Novel Heart Attack Care Technology7.7.2025 14:00:00 EEST | Press release

CorFlow Therapeutics AG (CorFlow), a pioneering company in the field of cardiac care targeting microvascular disease, today announced that the U.S. Food & Drug Administration (FDA) has approved the company’s technology for investigational device exemption (IDE), which allows the pivotal clinical trial to begin at U.S. hospitals. CorFlow will now prepare these clinical trial sites to receive CorFlow systems, undergo training and begin enrolling patients being treated for heart attacks. The IDE Pivotal Trial, MOCA-II, is intended to prospectively validate the diagnostic accuracy of the proprietary CorFlow CoFl system in determining the presence or absence of microvsacular obstruction (MVO) during a primary PCI procedure. The primary endpoint compares the CoFI diagnostic reading to a reference standard of diagnosis by a cardiac MRI scan. The trial is approved to enroll over 200 STEMI patients at prestigious research institutions in both the United States and Europe. Having successfully co

Reply AI Music Contest - Announced the Winner of the First International Competition Connecting AI Technologies With Music and Live Performances7.7.2025 13:21:00 EEST | Press release

Reply, an international group specialized in the creation of new business models enabled by Artificial Intelligence, is proud to announce the winner of the first edition of the Reply AI Music Contest—an international competition, organized in collaboration with the Kappa FuturFestival, aimed at creatives from around the world interested in exploring new ways to combine music, visuals, and AI technologies within live performances. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250707851551/en/ The winner is the production ‘Sinvocea’ by DeLaurentis, a DJ and producer based in Paris, who incorporated AI into her electronic compositions, utilising AI-generated vocals and real-time processing. A pioneer in the use of AI in music since 2018, DeLaurentis incorporated these tools into her creative process: treating technology as an extension of her voice, she has developed a unique approach where real-time vocal improvisation genera

TH Global Capital Closes 4 Major M&A Deals in Australia in 4 Months Including the Sale of The Missing Link to Infosys7.7.2025 12:59:00 EEST | Press release

TH Global Capital, an award-winning global boutique investment bank with a presence in 13 countries, has closed four high profile deals in the first four months of 2025, including the sale of The Missing Link to Infosys for 120 million AUD. This marks its tenth cross border transaction in Australia over the past 18 months, cementing its position as the mid-market M&A boutique investment bank of choice in Australia and New Zealand. Sale of The Missing Link to Infosys – The Missing Link, an award-winning cybersecurity and IT services provider based in Sydney, will join Infosys to deliver cybersecurity solutions and expand Infosys’s presence in Australia. Sale of TMLabs to Coforge – TMLabs, a ServiceNow Elite partner and digital transformation leader headquartered in Sydney, strengthens Coforge’s ServiceNow capabilities in Australia and leverages TMLabs’ existing contracts. Sale of Skie to Bluprintx – TH Global Capital’s 13th transaction in ANZ and 12th Salesforce deal globally. Skie, a l

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye